Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.78−0.15 (-3.82%)
Close on Nov 17, 2026Market cap $184.00MP/E –Yield –
Nu Skin Enterprises pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Nu Skin Enterprises's pe ratio was 4.7× on Jul 31, 2026, against 69.2× a year earlier. Over the last 5 years it ranged from 2.3× to 81.4×, with a median of 15.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 4.7× | +0.3 |
| 2025 | Dec 31, 2025 | 4.4× | −64.8 |
| 2024 | Apr 30, 2024 | 69.2× | +52.7 |
| 2023 | Dec 29, 2023 | 16.5× | −40.5 |
| 2022 | Dec 30, 2022 | 57.0× | +45.5 |
| 2021 | Dec 31, 2021 | 11.5× | −6.9 |
| 2020 | Dec 31, 2020 | 18.4× | −1.4 |
| 2019 | Dec 31, 2019 | 19.8× | −2.0 |
| 2018 | Dec 31, 2018 | 21.8× | −3.1 |
| 2017 | Dec 29, 2017 | 24.9× | +5.4 |
| 2016 | Dec 30, 2016 | 19.5× | +3.7 |
| 2015 | Dec 31, 2015 | 15.8× | +8.4 |
| 2014 | Dec 31, 2014 | 7.4× | −43.1 |
| 2013 | Dec 31, 2013 | 50.4× | +39.3 |
| 2012 | Dec 31, 2012 | 11.2× | −11.0 |
| 2011 | Dec 30, 2011 | 22.2× | +7.0 |
| 2010 | Dec 31, 2010 | 15.2× | −11.1 |
| 2009 | Dec 31, 2009 | 26.3× | – |
See a number that looks wrong?